Navigation Links
Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
Date:10/30/2007

$0.31 $0.28 $1.21 $0.80

Weighted average shares

outstanding:

Basic 53,221 51,638 52,661 51,407

Diluted 54,857 53,180 54,210 53,001

Gen-Probe Incorporated

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Nine Months Ended

September 30,

2007 2006

Operating activities:

Net income $65,728 $42,364

Adjustments to reconcile net income to net cash

provided by operating activities:

Depreciation and amortization 25,518 19,752

Stock-based compensation charges 14,487 17,755

Stock option income tax benefits 2,031 111

Excess tax benefit from employee stock options (13,055) (8,232)

Loss on disposal of property and equipment 202 4

Changes in assets and liabilities:

Accounts receivable (15,861) 7,550

Inventories 2,660 (5,338)

Prepaid expenses (6,538) (682)

Other current assets (2,756) 507

Other long term assets (930) (1,305)

Accounts payable 1,116 (3,103)

Accrued salaries and employee benefits 6,328 2,821

Other accrued expenses 5,343 624

'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email: